Genetic Tests in Liver Cancer?

Описание: "🧬 If you or a loved one has just been diagnosed with liver cancer or bile duct cancer (cholangiocarcinoma) — there’s one question you must ask:

👉 “Should we do genetic testing?”

Most people think genetic tests are only for breast or colon cancer. But in liver and bile duct cancers, genomic profiling can reveal targetable mutations — opening doors to precision therapies.

✅ When do we consider genetic testing?
– In advanced hepatocellular carcinoma (HCC) → testing for mutations like MET, TP53 (especially after first-line treatments fail)
– In bile duct cancers (cholangiocarcinomas) → where up to 40% carry mutations like IDH1, FGFR2, BRAF (which can be treated with oral targeted drugs)
– In young patients or strong family history → germline testing may reveal inherited cancer syndromes

💡 Why it matters:
Genetic testing helps us move away from “one-size-fits-all” chemo — and towards personalized, precision cancer care.

📌 If you or someone you know is facing liver or bile duct cancer — don’t forget to ask your oncologist:
“Would genetic testing change our treatment plan?”

That one question could unlock more — and better — options.

#GeneticTesting #LiverCancer #BileDuctCancer #Cholangiocarcinoma #CancerAwareness #PrecisionOncology #TargetedTherapy #OncologyCare #CancerEducation #CancerSupport #HCC #CancerTreatmentOptions #PersonalizedMedicine #OncologyAwareness #ModernCancerCare

[genetic testing liver cancer, genomic profiling bile duct cancer, cholangiocarcinoma genetic testing, liver cancer targetable mutations, bile duct cancer targeted therapy, hepatocellular carcinoma genetic testing, precision oncology liver cancer, IDH1 FGFR2 mutations cholangiocarcinoma, germline testing liver cancer, personalized cancer treatment, targeted therapy in liver and bile duct cancer]"